Aprexis Strengthens Leadership Team to Further Momentum in the Healthcare Market
Aprexis Augments Healthcare and Financial Expertise
(firmenpresse) - BURLINGTON, VT -- (Marketwire) -- 10/11/11 -- , the leader in patient technology, today announced it has added two highly experienced executives to its leadership team to accelerate growth in the healthcare market. Peyton Marshall joins the Aprexis board of directors and also serves as acting Chief Financial Officer. Dan Schwendler joins as Senior Vice President of Sales and Marketing.
"Peyton Marshall and Dan Schwendler bring tremendous strengths to Aprexis," said Robert Squire, President and Chief Executive Officer of Aprexis Health Solutions. "Peyton's leadership skills and financial prowess will help Aprexis to achieve the next level of growth in revenue and market share. Dan's expertise and creativity will be vital assets as we increase market awareness of our , a product designed to enable pharmacists and other healthcare providers to conduct and manage patient consultations for which will improve patient care and medication adherence."
Marshall brings 15 years of life science management experience and 25 years of financial experience to Aprexis. Most recently a director and consultant to private life sciences and software companies, Marshall has previously served as Chief Financial Officer of three public life sciences companies, Panacos Pharmaceuticals, EPIX Pharmaceuticals and The Medicines Company. His experience includes private financings, public financings, acquisitions and business development transactions, and other managerial responsibilities in rapidly growing development stage organizations and commercial companies, including a period as Acting CEO at Panacos. Prior to his career in life sciences, Marshall was an investment banker primarily based in London. His areas of focus were capital markets product development and marketing at Goldman Sachs, Union Bank of Switzerland and The First Boston Corporation. Previously he served as an Assistant Professor of Economics at Vanderbilt University. Marshall holds an A.B. in economics from Davidson College and a Ph.D. in economics from the Massachusetts Institute of Technology.
Schwendler will be responsible for global sales and marketing and will focus on the continued market expansion of Aprexis. Schwendler has over 15 years of experience in marketing information technology and decision support systems in the healthcare industry. Prior to Aprexis, Schwendler was responsible for successfully building and rebuilding sales organizations at leading technology companies, including Verity, Inc., Vertek Corporation and Software Spectrum. Schwendler has a B.S. in International Business from the Rochester Institute of Technology.
Aprexis Health Solutions is the premier company empowering pharmacist and provider-led medication adherence. The company's easy to use, web-based software revolutionizes delivery of personalized medication therapy management (MTM) and patient-centric clinical services while increasing revenues. What sets Aprexis apart is its keen focus on providing the tools needed to conduct and manage more consistent and effective high-quality medication consultations so patients have better treatment outcomes and to reduce overall healthcare costs in our system.
Laura MacSweeney
Red Javelin Communications
781-395-6420
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.10.2011 - 13:00 Uhr
Sprache: Deutsch
News-ID 74654
Anzahl Zeichen: 0
contact information:
Town:
BURLINGTON, VT
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 217 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Aprexis Strengthens Leadership Team to Further Momentum in the Healthcare Market"
steht unter der journalistisch-redaktionellen Verantwortung von
Aprexis Health Solutions (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
